Recently, the National Pharmaceutical Project was invited to participate in the 12th Building Information Model of Hubei Province ( BIM) Design Competition Exchange Meeting, with from34 of the home unit103 the project team competes on the same stage. In this competition, the National Pharmaceutical Engineering Design" china Resources Boya Biopharmaceutical Group Co., Ltd. Blood Products Intelligent Factory (Phase I) Construction Project" won the third prize of industrial engineering.

Based on three-dimensional design, the participating team of Sinoparma Engineering has built a standardized and intelligent equipment library and family library system, and formulated efficient data and information flow management rules, realizing digital deep collaboration among multiple disciplines and integrated design of the whole process. Through the mechanical and electrical professional forward design optimization, the precise positioning of the reserved hole, the intelligent statistics of engineering quantity and the fine control of materials, combined with collision inspection and REVIT frontiers such as the secondary development of the platform BIM with the application of technology, the team broke through the limitations of the traditional design model and significantly improved the design efficiency and quality of the project. This series of innovative practices demonstrates excellence in the field of pharmaceutical engineering design and construction management.

As a core enterprise of China Pharmaceutical Group focusing on the construction of pharmaceutical engineering, Sinopharm Engineering has always adhered to leading the progress of the industry with technological innovation, constantly strengthening technological research efforts, and providing customers with high-quality engineering and technical services. Looking forward to the future, Sinopharm will continue to give full play to its advanced digital experience and advantages, promote the construction of digital factories in the group and industry, continue to build industry benchmark projects, and contribute to the high-quality development of China's pharmaceutical and health industry.